1. Batch of contaminated methotrexate in Lebanon and Yemen

   News item 21 January 2023 Pages: 1 - 1

2. Children die after drinking cough syrup containing ethylene glycol

   News item 21 January 2023 Pages: 2 - 2

3. GFA Production recalls burn cream products due to microbial contamination

   News item 21 January 2023 Pages: 3 - 3

4. Glute Master recalls all batches of Maxx products in Australia

   News item 21 January 2023 Pages: 4 - 4

5. Levetiracetam-related behavioural AEs in patients in neurocritical care

   Clinical study 21 January 2023 Pages: 5 - 5

6. Terlipressin may cause respiratory failure and septic shock

   News item 21 January 2023 Pages: 6 - 6

7. Thyroid dysfunction after COVID-19 vaccination

   News item 21 January 2023 Pages: 7 - 7

8. Dapagliflozin: no increased risk of acute liver injury or severe UTI complications

   Clinical study 21 January 2023 Pages: 8 - 8

9. DPP-4 inhibitors have differing AE trends

   Clinical study 21 January 2023 Pages: 9 - 9

10. Immune-related AEs associated with outcomes during dual ICI therapy

    Clinical study 21 January 2023 Pages: 10 - 10

11. JYNNEOS vaccine safe for prevention of monkeypox

    Clinical study 21 January 2023 Pages: 11 - 11

12. No increase in risk of myocarditis in elderly after influenza vaccination

    Clinical study 21 January 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 21 January 2023 Pages: 13 - 13

14. Acalabrutinib

    Case report 21 January 2023 Pages: 14 - 14

15. Acitretin/ciclosporin/steroids

    Case report 21 January 2023 Pages: 15 - 15

16. Ad26.COV2-S

    Case report 21 January 2023 Pages: 16 - 16

17. Adalimumab

    Case report 21 January 2023 Pages: 17 - 17

18. Adalimumab/azathioprine

    Case report 21 January 2023 Pages: 18 - 18

19. Adalimumab/isoniazid/methotrexate/sulfasalazine

    Case report 21 January 2023 Pages: 19 - 19

20. Afatinib/bevacizumab/osimertinib

    Case report 21 January 2023 Pages: 20 - 20

21. Afatinib/pembrolizumab

    Case report 21 January 2023 Pages: 21 - 21

22. Allopurinol

    Case report 21 January 2023 Pages: 22 - 22

23. Alpelisib

    Case report 21 January 2023 Pages: 23 - 23

24. Ambrisentan

    Case report 21 January 2023 Pages: 24 - 24

25. Amiodarone

    Case report 21 January 2023 Pages: 25 - 25

26. Amphotericin B

    Case report 21 January 2023 Pages: 26 - 26

27. Amphotericin-B

    Case report 21 January 2023 Pages: 27 - 27

28. Amphotericin-B

    Case report 21 January 2023 Pages: 28 - 28

29. Amphotericin-B

    Case report 21 January 2023 Pages: 29 - 29

30. Amphotericin-B liposomal/flucytosine

    Case report 21 January 2023 Pages: 30 - 30

31. Amphotericin-b liposomal/posaconazole

    Case report 21 January 2023 Pages: 31 - 31

32. Amphotericin-B-liposomal

    Case report 21 January 2023 Pages: 32 - 32

33. Anakinra

    Case report 21 January 2023 Pages: 33 - 33

34. Anakinra/anti-cd19-anti-cd20-bispecific-lentiviral-chimeric-antigen-receptor-t-cell-therapy/axicabtagene-ciloleucel

    Case report 21 January 2023 Pages: 34 - 34

35. Anakinra/mycophenolate-mofetil/steroids

    Case report 21 January 2023 Pages: 35 - 35

36. Analgesics

    Case report 21 January 2023 Pages: 36 - 36

37. Analgesics

    Case report 21 January 2023 Pages: 37 - 37

38. Anesthetics/atropine/rocuronium-bromide

    Case report 21 January 2023 Pages: 38 - 38

39. Antibacterials

    Case report 21 January 2023 Pages: 39 - 39

40. Antibacterials

    Case report 21 January 2023 Pages: 40 - 40

41. Antibacterials/immunosuppresants

    Case report 21 January 2023 Pages: 41 - 41

42. Antidepressants/oxcarbazepine

    Case report 21 January 2023 Pages: 42 - 42

43. Antiepileptic drugs

    Case report 21 January 2023 Pages: 43 - 43

44. Antiepileptic-drugs/general-anaesthetics/hypnosedatives

    Case report 21 January 2023 Pages: 44 - 44

45. Antifungals/antineoplastics

    Case report 21 January 2023 Pages: 45 - 45

46. Antifungals/immunosuppressants

    Case report 21 January 2023 Pages: 46 - 46

47. Antihistamines/colchicine/omalizumab

    Case report 21 January 2023 Pages: 47 - 47

48. Antimalarials/doxycycline/steroids

    Case report 21 January 2023 Pages: 48 - 48

49. Antineoplastic drugs

    Case report 21 January 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 21 January 2023 Pages: 50 - 50